Tuesday, November 24, 2009, 4:06pm SGT - The Singapore stock market closes in 54 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Par Pharmaceutical Companies Inc. (PRX)

At 5:02AM SGT: 23.99 USD   0.00 (0.00%)  
 MORE ON PRX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 PHARMACUTICAL CO (NYSE:PRX) Delayed quote dataEdit
Last Trade:23.99 USD
Trade Time:5:02AM SGT
Change: 0.00 (0.00%)
Prev Close:23.99
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:26.43
Day's Range:N/A - N/A
52wk Range:8.57 - 24.23
Volume:0
Avg Vol (3m):505,186
Market Cap:835.31M
P/E (ttm):21.48
EPS (ttm):1.12
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add PRX to Portfolio   Download Data

 HEADLINES 
•Drugmaker Par Shapes A Base But Needs Time
Investor's Business Daily (Sat, Nov 21)
•Par Pharmaceutical to Host Analyst Day on December 3rd
PR Newswire (Tue, Nov 17)
•Par Pharma gets FDA approval for generic Ultram ER
AP (Mon, Nov 16)
•UPDATE - Par Pharma gets FDA nod for generic version of Ultram
at Reuters (Mon, Nov 16)
•Par Pharmaceutical Receives Final Approval to Market Generic Ultram(R) ER
PR Newswire (Mon, Nov 16)
•PAR PHARMACEUTICAL COMPANIES, INC. Financials
EDGAR Online Financials (Fri, Nov 13)
•[$$] Biotech Stock Mailbag: Cardium Therapeutics
at RealMoney by TheStreet.com (Fri, Nov 13)
•New Star Analyst Rankings for PHARMACUTICAL CO
StarMine (Tue, Nov 10)
•Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convert
PR Newswire (Tue, Nov 10)
•Par 3Q profit surges on product sales
AP (Fri, Nov 6)
More Headlines for PRX...
 ANALYST 
EPS Est (next year) (Dec-09) :2.46
EPS Est (in 2 years) (Dec-10) :1.60
Avg Rec (current)*:2.3
PEG Ratio:0.18
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Par Pharmaceutical Companies, Inc., through its subsidiary, Par Pharmaceutical, Inc. develops, manufactures, and distributes generic and branded pharmaceuticals drugs in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices